TREM2 splice isoforms generate soluble TREM2 species that disrupt long-term potentiation
Abstract Background TREM2 is a transmembrane receptor expressed by myeloid cells and acts to regulate their immune response. TREM2 governs the response of microglia to amyloid and tau pathologies in the Alzheimer’s disease (AD) brain. TREM2 is also present in a soluble form (sTREM2), and its CSF lev...
Main Authors: | Miguel Moutinho, Israel Coronel, Andy P. Tsai, Gonzalo Viana Di Prisco, Taylor Pennington, Brady K. Atwood, Shweta S. Puntambekar, Daniel C. Smith, Pablo Martinez, Seonggyun Han, Younghee Lee, Cristian A. Lasagna-Reeves, Bruce T. Lamb, Stephanie J. Bissel, Kwangsik Nho, Gary E. Landreth |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-02-01
|
Series: | Genome Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13073-023-01160-z |
Similar Items
-
Function of TREM1 and TREM2 in Liver-Related Diseases
by: Huifang Sun, et al.
Published: (2020-12-01) -
TREM-1, TREM-2 and their association with disease severity in patients with COVID-19
by: Ruyue Fan, et al.
Published: (2023-12-01) -
TREM2 Mediates Microglial Anti-Inflammatory Activations in Alzheimer’s Disease: Lessons Learned from Transcriptomics
by: Feng Xue, et al.
Published: (2021-02-01) -
Does Soluble TREM2 Protect Against Alzheimer's Disease?
by: Guy C. Brown, et al.
Published: (2022-01-01) -
The ratio of urinary TREM-1/TREM-2 mRNA expression in chronic kidney disease and renal fibrosis
by: Yuhan Cao, et al.
Published: (2021-01-01)